This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Berg, K. Articles by Høgset, A. Search for Related Content PubMed PubMed Citation Articles by Berg, K. Articles by Høgset, A.

Site-Specific Drug Delivery by Photochemical Internalization Enhances the Antitumor Effect of Bleomycin

Authors' Affiliations: Departments of ¹ Radiation Biology and ² Oncologic Surgery, the Norwegian Radium Hospital, Montebello, and ³ PCI Biotech AS, Oslo, Norway

Requests for reprints: Kristian Berg, Department of Radiation Biology, the Norwegian Radium Hospital, Montebello, N-0310 Oslo, Norway. Phone: 47-2293-4260; Fax: 47-2293-4270; E-mail: kristian.berg{at}labmed.uio.no.

Purpose: Photochemical internalization is under development for improving macromolecular therapy by inducing photochemical damage to endocytic vesicles. This damage leads to the release of therapeutic macromolecules entrapped in endocytic vesicles into the cytosol. The macromolecules may in this way be able to interact with therapeutic targets instead of being degraded by lysosomal hydrolases. Bleomycin is used in several standard cancer chemotherapy regimens. Its hydrophilic and relatively large chemical structure limits its ability to penetrate membrane structures, which causes the accumulation of bleomycin in endocytic vesicles. The purpose of this study was to evaluate the therapeutic potential of aluminum phthalocyanine disulfonate (AlPcS_2a)–based photochemical delivery of bleomycin.

Experimental Design: Three tumors of different origin were grown s.c. in BALB/c (nu/nu) mice. The photosensitizer AlPcS_2a and bleomycin were systemically administered and the tumor area was exposed to red light when the tumor volume had reached 100 mm³. The tumor volume was measured frequently after treatment and the time for the tumor volume to reach 800 to 1,000 mm³ was selected as the end point.

Results: The photochemical delivery of bleomycin induced a delayed tumor regrowth, and in two out of three tumor models, lead to 60% complete response, whereas no complete responses were seen after treatment with bleomycin alone. A statistical model to assess synergism was established. Combination of the photochemical treatment and bleomycin was found to induce a synergistic delay in tumor growth.

Conclusion: AlPcS_2a-based photochemical internalization of bleomycin induces a synergistic inhibition of tumor growth in three different tumor models. This treatment combination should be further considered for clinical utilization.

This article has been cited by other articles:

				A. Weyergang, O. Kaalhus, and K. Berg Photodynamic therapy with an endocytically located photosensitizer cause a rapid activation of the mitogen-activated protein kinases extracellular signal-regulated kinase, p38, and c-Jun NH2 terminal kinase with opposing effects on cell survival Mol. Cancer Ther., June 1, 2008; 7(6): 1740 - 1750. [Abstract] [Full Text] [PDF]

				P. K. Selbo, A. Weyergang, A. Bonsted, S. G. Bown, and K. Berg Photochemical Internalization of Therapeutic Macromolecular Agents: A Novel Strategy to Kill Multidrug-Resistant Cancer Cells J. Pharmacol. Exp. Ther., November 1, 2006; 319(2): 604 - 612. [Abstract] [Full Text] [PDF]